L'azitromicina

Una nuova arma per la terapia sistemica delle manifestazioni acneiche infiammatorie

Translated title of the contribution: Azithromycin for the systemic treatment of inflammatory acneic lesions: An open study

R. Caputo, M. Barbareschi, S. Veraldi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim. Azithromycin is an azalide antimicrobial agent active in skin infections with Propionibacterium acnes and in the literature there are no reports of PA resistance against it. Azithromycin has pharmacokinetic properties that give the possibility of pulse-therapies. It also has anti-inflammatory activity and it is not photo-active. The aim of this report is to show the efficacy and tolerability of azithromycin in the treatment of inflammatory acne, inflammatory rosacea and perioral dermatitis. Methods. An open study was carried out on 52 patients including: 40 patients affected by inflammatory acne, 6 patients with inflammatory rosacea and 6 patients with perioral dermatitis. In all these patients the basic treatment scheduled was azithromycin 500 mg/day for 3 consecutive days a week for 4 weeks. Results. The treated cases of inflammatory acne, inflammatory rosacea and perioral dermatitis showed a marked reduction of signs and symptoms after the scheduled azithromycin dosage. Conclusions. On the basis of these results, azithromycin is effective in about 75% of patients, e.g. the same percentage reached by means of the use of other oral antibiotics. The advantages of this scheme of treatment may be summarized as follows: - the pulse therapy significantly increases patients' compliance, because of the reduced total number of administrations of the drug; furthermore, it is well accepted by younger patients' parents; - good tolerability; - the drug is not phototoxic: therefore, it may be used with safety also in the summertime; - no case of P. acnes resistance have been up to now recorded in the literature.

Original languageItalian
Pages (from-to)327-331
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Volume138
Issue number4
Publication statusPublished - 2003

Fingerprint

Azithromycin
Perioral Dermatitis
Rosacea
Propionibacterium acnes
Therapeutics
Acne Vulgaris
Patient Compliance
Anti-Infective Agents
Pharmaceutical Preparations
Signs and Symptoms
Anti-Inflammatory Agents
Pharmacokinetics
Parents
Anti-Bacterial Agents
Safety
Skin
Infection

ASJC Scopus subject areas

  • Dermatology

Cite this

L'azitromicina : Una nuova arma per la terapia sistemica delle manifestazioni acneiche infiammatorie. / Caputo, R.; Barbareschi, M.; Veraldi, S.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 138, No. 4, 2003, p. 327-331.

Research output: Contribution to journalArticle

@article{a8de266cd5ef46e991269e2142768d53,
title = "L'azitromicina: Una nuova arma per la terapia sistemica delle manifestazioni acneiche infiammatorie",
abstract = "Aim. Azithromycin is an azalide antimicrobial agent active in skin infections with Propionibacterium acnes and in the literature there are no reports of PA resistance against it. Azithromycin has pharmacokinetic properties that give the possibility of pulse-therapies. It also has anti-inflammatory activity and it is not photo-active. The aim of this report is to show the efficacy and tolerability of azithromycin in the treatment of inflammatory acne, inflammatory rosacea and perioral dermatitis. Methods. An open study was carried out on 52 patients including: 40 patients affected by inflammatory acne, 6 patients with inflammatory rosacea and 6 patients with perioral dermatitis. In all these patients the basic treatment scheduled was azithromycin 500 mg/day for 3 consecutive days a week for 4 weeks. Results. The treated cases of inflammatory acne, inflammatory rosacea and perioral dermatitis showed a marked reduction of signs and symptoms after the scheduled azithromycin dosage. Conclusions. On the basis of these results, azithromycin is effective in about 75{\%} of patients, e.g. the same percentage reached by means of the use of other oral antibiotics. The advantages of this scheme of treatment may be summarized as follows: - the pulse therapy significantly increases patients' compliance, because of the reduced total number of administrations of the drug; furthermore, it is well accepted by younger patients' parents; - good tolerability; - the drug is not phototoxic: therefore, it may be used with safety also in the summertime; - no case of P. acnes resistance have been up to now recorded in the literature.",
keywords = "Acne rosacea, drug therapy, Acne vulgaris, drug therapy, Azithromycin, Dermatitis",
author = "R. Caputo and M. Barbareschi and S. Veraldi",
year = "2003",
language = "Italian",
volume = "138",
pages = "327--331",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - L'azitromicina

T2 - Una nuova arma per la terapia sistemica delle manifestazioni acneiche infiammatorie

AU - Caputo, R.

AU - Barbareschi, M.

AU - Veraldi, S.

PY - 2003

Y1 - 2003

N2 - Aim. Azithromycin is an azalide antimicrobial agent active in skin infections with Propionibacterium acnes and in the literature there are no reports of PA resistance against it. Azithromycin has pharmacokinetic properties that give the possibility of pulse-therapies. It also has anti-inflammatory activity and it is not photo-active. The aim of this report is to show the efficacy and tolerability of azithromycin in the treatment of inflammatory acne, inflammatory rosacea and perioral dermatitis. Methods. An open study was carried out on 52 patients including: 40 patients affected by inflammatory acne, 6 patients with inflammatory rosacea and 6 patients with perioral dermatitis. In all these patients the basic treatment scheduled was azithromycin 500 mg/day for 3 consecutive days a week for 4 weeks. Results. The treated cases of inflammatory acne, inflammatory rosacea and perioral dermatitis showed a marked reduction of signs and symptoms after the scheduled azithromycin dosage. Conclusions. On the basis of these results, azithromycin is effective in about 75% of patients, e.g. the same percentage reached by means of the use of other oral antibiotics. The advantages of this scheme of treatment may be summarized as follows: - the pulse therapy significantly increases patients' compliance, because of the reduced total number of administrations of the drug; furthermore, it is well accepted by younger patients' parents; - good tolerability; - the drug is not phototoxic: therefore, it may be used with safety also in the summertime; - no case of P. acnes resistance have been up to now recorded in the literature.

AB - Aim. Azithromycin is an azalide antimicrobial agent active in skin infections with Propionibacterium acnes and in the literature there are no reports of PA resistance against it. Azithromycin has pharmacokinetic properties that give the possibility of pulse-therapies. It also has anti-inflammatory activity and it is not photo-active. The aim of this report is to show the efficacy and tolerability of azithromycin in the treatment of inflammatory acne, inflammatory rosacea and perioral dermatitis. Methods. An open study was carried out on 52 patients including: 40 patients affected by inflammatory acne, 6 patients with inflammatory rosacea and 6 patients with perioral dermatitis. In all these patients the basic treatment scheduled was azithromycin 500 mg/day for 3 consecutive days a week for 4 weeks. Results. The treated cases of inflammatory acne, inflammatory rosacea and perioral dermatitis showed a marked reduction of signs and symptoms after the scheduled azithromycin dosage. Conclusions. On the basis of these results, azithromycin is effective in about 75% of patients, e.g. the same percentage reached by means of the use of other oral antibiotics. The advantages of this scheme of treatment may be summarized as follows: - the pulse therapy significantly increases patients' compliance, because of the reduced total number of administrations of the drug; furthermore, it is well accepted by younger patients' parents; - good tolerability; - the drug is not phototoxic: therefore, it may be used with safety also in the summertime; - no case of P. acnes resistance have been up to now recorded in the literature.

KW - Acne rosacea, drug therapy

KW - Acne vulgaris, drug therapy

KW - Azithromycin

KW - Dermatitis

UR - http://www.scopus.com/inward/record.url?scp=0141920512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141920512&partnerID=8YFLogxK

M3 - Articolo

VL - 138

SP - 327

EP - 331

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 4

ER -